Medical Research

IMIC Medical Research Center Adds New Agents to ACTIV-2 Clinical Trial in Miami Dade to Investigate Early COVID-19 Treatments

IMIC Medical Research Center Adds New Agents to ACTIV-2 Clinical Trial in Miami Dade to Investigate Early COVID-19 Treatments

WHAT:           The ACTIV-2 clinical trial, which is investigating treatments for early COVID-19, announces the addition of new agents to the study. Developed by Brii Biosciences, BRII-196 and BRII-198 are monoclonal antibodies that each target a different part of SARS-CoV-2, the…

Maintaining Heart Function After a Heart Attack

Maintaining Heart Function After a Heart Attack

An article published in Experimental Biology and Medicine (Volume 246, Issue 5, March, 2021) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220969844) reports a new therapeutic option for preventing long-term damage to the heart after a heart attack. The study, led by Dr. Y. James Kang, in the…

Advances in Transforming Growth Factor-β Signaling

Advances in Transforming Growth Factor-β Signaling

An article published in Experimental Biology and Medicine (Volume 246, Issue 4, February, 2021) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220966296) reports a new mechanism for modulating transforming-growth factor beta (TGF-β) signaling. The study, led by Dr. Thomas Thompson, in the Department of Molecular Genetics, Biochemistry and…

Vladimir Potanin Supports Leading Russian Scientists to Propel Fundamental Research of Human Brain in Russia

Vladimir Potanin Supports Leading Russian Scientists to Propel Fundamental Research of Human Brain in Russia

Vladimir Potanin donated 500 million rubles ($6.7ml) to the groundbreaking project, aimed for creation of smart materials with pre-programmed properties, allowing development of conceptually new technologies. The project envisages the establishment of a brand-new Laboratory of Programmable Functional Materials in…

Not a Normal 20 Year Anniversary for Cmed

Not a Normal 20 Year Anniversary for Cmed

Cmed, a full-service technology-led CRO that specializes in oncology, immuno-oncology, cell and gene therapy and rare diseases is celebrating its 20 year anniversary. These are not normal times and Cmed is not a normal CRO or technology provider. Instead, it…

Softwave® Tissue Regeneration Technologies Announces Landmark Trial for Acute Traumatic Spinal Cord Injuries

Softwave® Tissue Regeneration Technologies Announces Landmark Trial for Acute Traumatic Spinal Cord Injuries

SoftWave® Tissue Regeneration Technologies, a disruptive bio-medical device company, announces the beginning of a trial for “Extracorporeal Shock Wave Therapy in Acute Traumatic Complete and Incomplete Cross – Sectional Lesions.” The trial will be sponsored by the Austrian Workers’ Compensation…

European multicentre study – first expectations fulfilled

European multicentre study – first expectations fulfilled

The pathway to a correct diagnosis in epilepsy patients is often very long. Furthermore, approx. 30% of all patients with epilepsy cannot be treated adequately in spite of a variety of medicinal options. The use of technical options for treatment…

Predicting Alzheimer's Disease-Like Memory Loss Before It Strikes

Predicting Alzheimer's Disease-Like Memory Loss Before It Strikes

For a person with Alzheimer’s disease, there’s no turning back the clock. By the time she begins to experience memory loss and other worrisome signs, cognitive decline has already set in. And decades of clinical trials have failed to produce…

The FamilieSCN2A Foundation, Inc Awards $100K in Inaugural Rare Genetic Research Grants

The FamilieSCN2A Foundation, Inc Awards $100K in Inaugural Rare Genetic Research Grants

​​​​The FamilieSCN2A Foundation has announced an award of $100,000 to two post-doctoral research efforts in its inaugural “Action Potential” Research Grant initiative to promote scientific understanding of rare but potentially devastating SCN2A gene mutations. The grants are designed to support…

The Ehlers-Danlos Society Announces Worldwide Research Study to Identify the Genetic Cause of Hypermobile Ehlers-Danlos Syndrome

The Ehlers-Danlos Society Announces Worldwide Research Study to Identify the Genetic Cause of Hypermobile Ehlers-Danlos Syndrome

​The Ehlers-Danlos Society is excited to announce the start of recruitment for participants in the Hypermobile Ehlers-Danlos Syndrome Genetic Research Study, devoted to finding the underlying genetic markers for hypermobile EDS (hEDS). Since the announcement of the extraordinary “Moonshot” donation…

Heart Remodeling During Pregnancy and the Early Postpartum Period

Heart Remodeling During Pregnancy and the Early Postpartum Period

An article published in Experimental Biology and Medicine (Volume 243, Issue 15/16, November, 2018) (https://journals.sagepub.com/doi/pdf/10.1177/1535370218818457) provides new insights regarding the molecular events underlying cardiac remodeling during pregnancy and the early post-partum period. The study, led by Dr. Holly LaVoie, Department…

Primate CRO Alpha Genesis Continues Expansion Efforts With $3M Commitment

Primate CRO Alpha Genesis Continues Expansion Efforts With $3M Commitment

Primate contract research organization Alpha Genesis today announced the second phase of its multi-year expansion effort, committing an additional $3M over the next two years towards new construction and hiring to further enhance the Company's product and service offerings. This announcement…

Development of Long-Acting Local Anesthetics

Development of Long-Acting Local Anesthetics

Lotus Clinical Research is pleased to announce that our Founder and Chief Executive Officer, Dr. Neil Singla, presented at the 12th annual Pain & Migraine Therapeutics Conference in San Francisco, California. Dr. Singla discussed "Development of Long-Acting Local Anesthetics: Clinical…

OccuPro Research Highlights the Success of OccuPro's Functional Capacity Evaluation

OccuPro, a company providing medical professionals and employers with the latest in functional capacity evaluation software and continuing education, is highlighting a 2018 publication titled “An evaluation of the inter-rater and intra-rater reliability of OccuPro’s functional capacity evaluation.” The publication…

Alpha Genesis Primate Research Center Launches New Online Resource

The Alpha Genesis Primate Research Center (AGPRC) has launched a new website to raise awareness of biomedical and behavioral research with primates that seeks to improve human and animal health. The website, PrimateResearch.com, offers a user-friendly, informative experience for people across the world who are interested in…

Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors

Focusing on its Manufacturing, Fortuna Fix (“Fortuna”), a private Regenerative Medicine company announced today the appointment of Mr Madhavan Balachandran to its board of directors, bringing Mr Balachandran’s extensive experience in chemistry, manufacturing and controls (CMC) to Fortuna and reinforcing…

Overcoming Bioanalytical Challenges in Drug Discovery and Biomarker Identification, New Webinar Hosted by Xtalks

In this live presentation, featured speakers from KCAS Gene Ray, Ph.D., Senior Scientific Advisor and Lawrence Goodwin, Executive Director of Bioanalytical R&D and LC-MS/MS Services will highlight bioanalytical challenges in drug discovery and some potential solutions. Examples to be presented…

ReGenTree Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome

ReGenTree Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome

ReGenTree LLC (the "Company"), a joint venture between GtreeBNT and RegeneRx Biopharmaceuticals, announced today the outcome of discussions with FDA regarding the results of the completed phase 3 clinical trial (ARISE-2) and the future development requirements for a New Drug Application…

New Xtalks Webinar to Address the Increasing Demand for Single-Site Pre-Market Approval Models in the Pursuit of Companion Diagnostic Development (CDx)

New Xtalks Webinar to Address the Increasing Demand for Single-Site Pre-Market Approval Models in the Pursuit of Companion Diagnostic Development (CDx)

Join esteemed speakers from Covance including Steven Anderson, PhD, Senior Vice President and Chief Scientific Officer, and Tom Turi, PhD, Vice President of Companion Diagnostics for a live session on Wednesday, March 21, 2018 at 11 a.m. EDT (3 p.m.…

The CHEF1® Expression Technology Advantage for Accelerated Biologics Production, New Webinar Hosted by Xtalks

The CHEF1® Expression Technology Advantage for Accelerated Biologics Production, New Webinar Hosted by Xtalks

Biologics’ proprietary CHEF1® Expression System accelerates development of cell lines for cGMP biologics production. The innovative platform utilizes robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and CHEF1 expression plasmids, to produce high…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login